Cargando…

Immune Cells and Transcriptional Signatures Revealed Novel Regulators and Predict Clinical Response to Biologic Therapy in Ulcerative Colitis

Detalles Bibliográficos
Autor principal:	Savkovic, Suzana D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431358/ https://www.ncbi.nlm.nih.gov/pubmed/36052276 http://dx.doi.org/10.33696/immunology.3.116

Ejemplares similares

Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy
por: Penrose, Harrison M., et al.
Publicado: (2021)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Biological therapy for ulcerative colitis
por: Arora, Zubin, et al.
Publicado: (2015)

Potential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis
por: Zhang, Run-Feng, et al.
Publicado: (2021)

3253 Identification of Immune Cell Profiles and Molecular Pathways in Inflammatory Bowel Disease Driving Non-Response to Biologic Therapy
por: Penrose, Harrison Michael, et al.
Publicado: (2019)

Transcription Factors That Regulate the Pathogenesis of Ulcerative Colitis
por: Zhang, Bing, et al.
Publicado: (2020)

Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids
por: Sarvestani, Samaneh K., et al.
Publicado: (2018)

Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis
por: Xu, Mengmeng, et al.
Publicado: (2022)

Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis
por: Diab, Joseph, et al.
Publicado: (2019)

Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis
por: Wang, Wenxin, et al.
Publicado: (2023)

Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
por: Lee, Hae Chan, et al.
Publicado: (2023)

A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses
por: Mo, Shaocong, et al.
Publicado: (2023)

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans
por: Viennois, Emilie, et al.
Publicado: (2017)

Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
por: Shibuya, Tomoyoshi, et al.
Publicado: (2019)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022)

Current and Emerging Biologics for Ulcerative Colitis
por: Park, Sung Chul, et al.
Publicado: (2015)

Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer
por: Pan, Zhaoji, et al.
Publicado: (2023)

Use of Novel Biological Agent in Severe Ulcerative Colitis with Poor Response to Initial Therapy: A Case Report
por: Bhandari, Abashesh, et al.
Publicado: (2022)

Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
por: Ning, Yumei, et al.
Publicado: (2023)

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
por: Middha, Pooja, et al.
Publicado: (2023)

Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy
por: Iizuka, Masahiro, et al.
Publicado: (2022)

Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis
por: Chen, Zi-An, et al.
Publicado: (2021)

Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures
por: Shome, Mahasish, et al.
Publicado: (2022)

Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis
por: Arivarasan, K, et al.
Publicado: (2016)

Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis
por: Sakai, Kazuko, et al.
Publicado: (2021)

Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies
por: Popov, Jelena, et al.
Publicado: (2021)

Novel oral-targeted therapies for mucosal healing in ulcerative colitis
por: Antonelli, Elisabetta, et al.
Publicado: (2018)

Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?
por: Cui, Guanglin, et al.
Publicado: (2022)

Cutaneous thrombotic vasculopathy related to poorly controlled ulcerative colitis
por: Cheeley, Justin, et al.
Publicado: (2018)

Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study
por: Bertani, Lorenzo, et al.
Publicado: (2020)

Cerebral venous thrombosis revealing an ulcerative colitis
por: Taous, Abdellah, et al.
Publicado: (2016)

Medical Therapy of Active Ulcerative Colitis
por: Bürger, Martin, et al.
Publicado: (2015)

Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis
por: Chen, Xuanfu, et al.
Publicado: (2021)

Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network
por: Feng, Jing, et al.
Publicado: (2021)

Bioinformatis analysis reveals possible molecular mechanism of PXR on regulating ulcerative colitis
por: Guo, Hanze, et al.
Publicado: (2021)

Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis
por: Gao, Caifang, et al.
Publicado: (2022)

MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
por: Schaefer, Jeremy S, et al.
Publicado: (2015)

Combined Signature of the Fecal Microbiome and Plasma Metabolome in Patients with Ulcerative Colitis
por: Sun, Meiling, et al.
Publicado: (2019)

A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
por: Xi, Li, et al.
Publicado: (2022)

Treatment Pathways Leading to Biologic Therapies for Ulcerative Colitis and Crohn's Disease in the United States
por: Siegel, Corey A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hvub4o43tgsklep5lon29vtiat